Dr Anastasios Kartas

All Stories

1. 
   Oral Anticoagulation Choice and Dosage in Very Elderly Patients with Atrial Fibrillation

   Article • Journal of Cardiovascular Development and Disease, February 2025, MDPI AG

   Dr Anastasios Kartas

2. 
   Prognostic Impact of Body Mass Index in Atrial Fibrillation

   Article • Journal of Clinical Medicine, June 2024, MDPI AG

   Dr Anastasios Kartas

3. 
   Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

   Article • Journal of the American Heart Association, January 2024, Wolters Kluwer Health

   Dr Anastasios Kartas

4. 
   Risk of arterial thromboembolism, bleeding and mortality in atrial fibrillation patients with comorbid cancer: A systematic review and meta-analysis

   Article • Hellenic Journal of Cardiology, November 2023, Elsevier

   Dr Anastasios Kartas

5. 
   Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease

   Article • Journal of Clinical Medicine, April 2023, MDPI AG

   Dr Anastasios Kartas, Anastasios Papanastasiou

6. 
   Autoimmunity-related atrial fibrillation incidence: an emerging conundrum meriting further investigation

   Article • EP Europace, March 2023, Oxford University Press (OUP)

   Dr Anastasios Kartas

7. 
   Association of Health Status Metrics with Clinical Outcomes in Patients with Adult Congenital Heart Disease and Atrial Arrhythmias

   Article • Journal of Clinical Medicine, October 2022, MDPI AG

   Dr Anastasios Kartas

8. 
   Sex-Related Differences in Clinical Outcomes in Patients with Atrial Fibrillation and Coronary Artery Disease: A Sub-Study of the MISOAC-AF Randomized Controlled Trial

   Article • Journal of Clinical Medicine, October 2022, MDPI AG

   Dr Anastasios Kartas

9. 
   Polycystic Ovary Syndrome Triggers Atrial Conduction Disorders: A Systematic Review and Meta-Analysis

   Article • European Journal of Investigation in Health Psychology and Education, July 2022, MDPI AG

   Dr Anastasios Kartas

10. 
    The Adult Congenital Heart Disease Anatomic and Physiological Classification: Associations with Clinical Outcomes in Patients with Atrial Arrhythmias

    Article • Diagnostics, February 2022, MDPI AG

    Dr Anastasios Kartas

11. 
    The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations

    Article • Reviews in Endocrine and Metabolic Disorders, February 2022, Springer Science + Business Media

    Dr Anastasios Kartas, Anastasios Papanastasiou

12. 
    The Adult Congenital Heart Disease Anatomic and Physiological Classification: Associations with Clinical Outcomes in Patients with Atrial Arrhythmias

    Article • January 2022, MDPI AG

    Dr Anastasios Kartas

13. 
    Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, January 2022, SAGE Publications

    Dr Anastasios Kartas

14. 
    Prediction of long-term survival in patients with transfusion-dependent hemoglobinopathies: Insights from cardiac imaging and ferritin

    Article • Hellenic Journal of Cardiology, November 2021, Elsevier

    Dr Anastasios Kartas

15. 
    A novel prognostic tool to predict mortality in patients with atrial fibrillation: The BASIC-AF risk score

    Article • Hellenic Journal of Cardiology, September 2021, Elsevier

    Dr Anastasios Kartas

16. 
    Association of anticoagulant-related bleeding events with cancer detection in atrial fibrillation: A systematic review and meta-analysis

    Article • Hellenic Journal of Cardiology, September 2021, Elsevier

    Dr Anastasios Kartas, Anastasios Papanastasiou

17. 
    Τhe association of heart failure across left ventricular ejection fraction with mortality in atrial fibrillation

    Article • ESC Heart Failure, June 2021, Wiley

    Dr Anastasios Kartas

18. 
    Association of GRACE Risk Score with Coronary Artery Disease Complexity in Patients with Acute Coronary Syndrome

    Article • Journal of Clinical Medicine, May 2021, MDPI AG

    Dr Anastasios Kartas

19. 
    A case of intracoronary thrombus in acute coronary syndrome: Sometimes doing less is more

    Article • Hellenic Journal of Cardiology, May 2021, Elsevier

    Dr Anastasios Kartas

20. 
    Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial

    Article • Atherosclerosis, April 2021, Elsevier

    Dr Anastasios Kartas

21. 
    Prognostic significance of diabetes mellitus in patients with atrial fibrillation

    Article • Cardiovascular Diabetology, February 2021, Springer Science + Business Media

    Dr Anastasios Kartas

22. 
    Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial

    Article • BMC Cardiovascular Disorders, February 2021, Springer Science + Business Media

    Dr Anastasios Kartas

23. 
    Serum Ceramides as Prognostic Biomarkers of Large Thrombus Burden in Patients with STEMI: A Micro-Computed Tomography Study

    Article • Journal of Personalized Medicine, January 2021, MDPI AG

    Dr Anastasios Kartas

24. 
    Serum Ceramides as Prognostic Biomarkers of Large Thrombus Burden in Patients With STEMI: A Micro-Computed Tomography Study

    Article • January 2021, MDPI AG

    Dr Anastasios Kartas

25. 
    Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome

    Article • The American Journal of Cardiology, October 2020, Elsevier

    Dr Anastasios Kartas

26. 
    Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study

    Article • BMJ Open, September 2020, BMJ

    Dr Anastasios Kartas

27. 
    Thrombosis and thromboprophylactic strategies in the adult with Fontan circulation

    Article • International Journal of Cardiology Congenital Heart Disease, July 2020, Elsevier

    Dr Anastasios Kartas

28. 
    Non-Vitamin K Oral Anticoagulants in Adults with Congenital Heart Disease: A Systematic Review

    Article • Journal of Clinical Medicine, June 2020, MDPI AG

    Dr Anastasios Kartas

29. 
    Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trial

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2020, Oxford University Press (OUP)

    Dr Anastasios Kartas

30. 
    Rationale and design of a randomized study comparing Motivational Interviewing to Support Oral Anticoagulation adherence versus usual care in patients with nonvalvular atrial fibrillation: The MISOAC-AF trial

    Article • Hellenic Journal of Cardiology, April 2020, Elsevier

    Dr Anastasios Kartas

31. 
    Rationale and design of a prospective, single-arm trial for the evaluation of safety and feasibility of large thrombus burden aspiration in the context of ST elevation myocardial infarction

    Article • Hellenic Journal of Cardiology, April 2020, Elsevier

    Dr Anastasios Kartas

32. 
    Treatment practices and lipid profile of patients with acute coronary syndrome: results from a tertiary care hospital

    Article • Acta Cardiologica, June 2019, Taylor & Francis

    Dr Anastasios Kartas, Athanasios Koutsakis , Athina Tampaki

33. 
    Evolving oral anticoagulation patterns in patients with known AF during a hospitalization

    Article • Journal of Thrombosis and Thrombolysis, March 2019, Springer Science + Business Media

    Dr Anastasios Kartas

34. 
    The whole picture of Oral Anticoagulant use on discharged patients with AF

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, January 2019, SAGE Publications

    Dr Anastasios Kartas

35. 
    Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design

    Article • Hellenic Journal of Cardiology, October 2018, Elsevier

    Dr Anastasios Kartas